PT3592869T - Bactérias de christensenellaceae para uso como medicamento, em particular para tratamento de obesidade, doenças cardiometabólicas e doenças inflamatórias do intestino - Google Patents

Bactérias de christensenellaceae para uso como medicamento, em particular para tratamento de obesidade, doenças cardiometabólicas e doenças inflamatórias do intestino

Info

Publication number
PT3592869T
PT3592869T PT187147178T PT18714717T PT3592869T PT 3592869 T PT3592869 T PT 3592869T PT 187147178 T PT187147178 T PT 187147178T PT 18714717 T PT18714717 T PT 18714717T PT 3592869 T PT3592869 T PT 3592869T
Authority
PT
Portugal
Prior art keywords
diseases
obesity
drug
inflammatory bowel
specific bacteria
Prior art date
Application number
PT187147178T
Other languages
English (en)
Original Assignee
Ysopia Biosciences
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ysopia Biosciences filed Critical Ysopia Biosciences
Publication of PT3592869T publication Critical patent/PT3592869T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/145—Clostridium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Child & Adolescent Psychology (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PT187147178T 2017-03-10 2018-03-09 Bactérias de christensenellaceae para uso como medicamento, em particular para tratamento de obesidade, doenças cardiometabólicas e doenças inflamatórias do intestino PT3592869T (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1770237A FR3063646B1 (fr) 2017-03-10 2017-03-10 Bacteries specifiques pour leur utilisation comme medicament en particulier pour lutter contre le surpoids, l'obesite, les maladies cardiometaboliques et les maladies inflammatoires de l'intestin
FR1770822A FR3063647B1 (fr) 2017-03-10 2017-08-02 Bacteries specifiques pour leur utilisation comme medicament en particulier pour lutter contre le surpoids, l'obesite, les maladies cardiometaboliques et les maladies inflammatoires de l'intestin

Publications (1)

Publication Number Publication Date
PT3592869T true PT3592869T (pt) 2021-07-19

Family

ID=59521140

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187147178T PT3592869T (pt) 2017-03-10 2018-03-09 Bactérias de christensenellaceae para uso como medicamento, em particular para tratamento de obesidade, doenças cardiometabólicas e doenças inflamatórias do intestino

Country Status (7)

Country Link
US (2) US10681932B2 (pt)
EP (2) EP3592870A1 (pt)
DK (1) DK3592869T3 (pt)
ES (1) ES2884049T3 (pt)
FR (2) FR3063646B1 (pt)
PT (1) PT3592869T (pt)
WO (2) WO2018162726A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2763350B2 (es) * 2018-11-28 2020-10-13 Consejo Superior Investigacion Cepa de christensenella minuta y uso de la misma
FR3099054A1 (fr) 2019-07-24 2021-01-29 Institut National De La Recherche Agronomique (Inra) Souche de Christensenella pour son utilisation dans le traitement et la prévention d’une inflammation gastro-intestinale
FR3093642A1 (fr) * 2019-03-11 2020-09-18 Lnc Therapeutics Bactérie de la famille des Christensenellacées dans la prévention et/ou le traitement de maladies inflammatoires chroniques et/ou de cancers
JP2022525058A (ja) 2019-03-11 2022-05-11 イゾピア バイオサイエンシーズ 慢性炎症性疾患および／または炎症性消化器疾患および／または癌の予防および／または治療のためのクリステンセネラ科細菌
KR20210141541A (ko) * 2019-03-11 2021-11-23 와이소피아 바이오사이언시즈 만성 염증성 질환 및/또는 염증성 위장 질환 및/또는 암의 예방 및/또는 치료를 위한 크리스텐세넬라시아에 과의 박테리아
FR3095339A1 (fr) * 2019-04-25 2020-10-30 Lnc Therapeutics Bactérie de la famille des Christensenellacées dans la prévention et/ou le traitement de l’hypertriglycéridémie
EP3958882A1 (fr) * 2019-04-25 2022-03-02 YSOPIA Biosciences Bactérie de la famille des christensenellacées dans la prévention et/ou le traitement de l'hypertriglycéridémie
FR3097740B1 (fr) * 2019-06-25 2021-06-25 Lnc Therapeutics Bactérie de la famille des Christensenellacées et composition en contenant pour la prévention et/ou le traitement d’une perte de masse musculaire pathologique ou d’une maladie caractérisée par une perte de masse musculaire pathologique
FR3097739B1 (fr) * 2019-06-25 2022-03-04 Lnc Therapeutics Bactéries du microbiote intestinal et composition en contenant pour son utilisation dans la prévention et/ou le traitement de maladies caractérisées par l’excès de 2-hydroxyglutarate
FR3099053B1 (fr) 2019-07-24 2023-01-20 Inst Nat De La Rech Agronomique Inra Souches bacteriennes pour le traitement et la prevention d’une inflammation gastro-intestinale
WO2021041981A1 (en) * 2019-08-28 2021-03-04 Assembly Biosciences, Inc. Compositions comprising bacterial species and methods related thereto
CN111184748A (zh) * 2020-02-10 2020-05-22 农业农村部食物与营养发展研究所 一种改善肌肉萎缩的微生物菌剂及其应用
WO2022178209A1 (en) * 2021-02-19 2022-08-25 Evelo Biosciences, Inc. Compositions and methods for treating metabolic diseases and disorders using christensenellaceae bacteria
CN113069475B (zh) * 2021-04-06 2023-06-02 慕恩（广州）生物科技有限公司 一种细菌菌株及组合物和用途
WO2022213507A1 (zh) * 2021-04-06 2022-10-13 慕恩（广州）生物科技有限公司 一种细菌菌株及组合物、联用药物和用途
WO2023121955A1 (en) * 2021-12-20 2023-06-29 Tainnovation Inc. The methods of and compositions for treating obesity, obesity-related diseases or cancers using a n6-methyllysine/l-lysine mixture
CN116377070A (zh) * 2023-03-06 2023-07-04 臻傲生物科技检测(深圳)有限公司 预测结直肠癌或结直肠腺瘤风险的新型微生物标志物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3134509A4 (en) * 2014-04-23 2017-09-13 Cornell University Modulation of fat storage in a subject by altering population levels of christensenellaceae in the gi tract

Also Published As

Publication number Publication date
US20180255821A1 (en) 2018-09-13
DK3592869T3 (da) 2021-07-26
EP3592870A1 (fr) 2020-01-15
WO2018162726A1 (fr) 2018-09-13
US20210352946A1 (en) 2021-11-18
FR3063647A1 (fr) 2018-09-14
FR3063646B1 (fr) 2021-07-30
US20180255819A1 (en) 2018-09-13
WO2018162738A1 (fr) 2018-09-13
US11044933B2 (en) 2021-06-29
EP3592869A1 (fr) 2020-01-15
FR3063646A1 (fr) 2018-09-14
US10681932B2 (en) 2020-06-16
FR3063647B1 (fr) 2019-06-07
ES2884049T3 (es) 2021-12-10
EP3592869B1 (fr) 2021-04-28

Similar Documents

Publication Publication Date Title
PT3592869T (pt) Bactérias de christensenellaceae para uso como medicamento, em particular para tratamento de obesidade, doenças cardiometabólicas e doenças inflamatórias do intestino
IL231536A (en) Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases
IL244668A0 (en) Preparations and formulations for the prevention and treatment of diabetes and obesity, and methods for their production and use in the control of glucose and calories
MA39710A (fr) Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin
PL2990045T3 (pl) Bifidobacterium animalis podgat. lactis do stosowania w zmniejszaniu bólu brzucha u kobiet po menopauzie
EP3187189A4 (en) Composition and medicinal product for reducing body weight and body fat, and use of said product
EP3187178A4 (en) Composition for reducing local fat and body weight, and pharmaceuticals and use thereof
ME03438B (me) DERIVAT 2-ACILAMINOTIAZOLA ZA UPOTREBU U PREVENCIJI ILI LEčENJU OBOLJENJA BESIKE / URINARNOG TRAKTA
ZA201903696B (en) Compositions for use in treating inflammatory bowel diseases and intestinal colitis
GB201108560D0 (en) Use of fermented wheat germ in the treatment of inflammatory bowel disease
EP2738176A4 (en) WATER-SOLUBLE CAMPTOTHECIN DERIVATIVE, PHARMACEUTICAL COMPOSITION THEREFOR AND ITS USE
MX2017007676A (es) Nuevos compuestos.
LT2576495T (lt) Nauji mesalazino dariniai, jų gavimo būdas ir naudojimas uždegiminių žarnyno ligų gydymui
IL249440A0 (en) Compounds, pharmaceutical preparations and their use in the treatment of neurodegenerative diseases
HK1217640A1 (zh) 藥物組合物及其用途以及所述藥物組合物用於按需避孕的施用方法
HK1208159A1 (en) Sorcs1 for use in the treatment of obesity and overweight sorcs1
IL272366A (en) Adamantylmethylamine derivatives and their uses as a pharmaceutical preparation
EP2789613A4 (en) 1,4-DIHYDRO-NAPHTHYRIDINE DERIVATIVE AND PHARMACEUTICAL COMPOSITION THEREOF AND ITS USE
EP3626235C0 (en) PHARMACEUTICAL PRODUCT, MEDICAL FOOD OR FOOD SUPPLEMENT FOR THE PREVENTION OF CANCER AND INFLAMMATORY DISEASES
HRP20182167T1 (hr) Derivati benzilhidroksida, njihova priprava i njihova terapeutska uporaba
GB201412588D0 (en) Use of a neurotoxin in the treatment of overweight,including obesity
GB201608841D0 (en) Use of neurotoxin in the treatment of overweight, including obesity
GB201415915D0 (en) Improvements in and Relating to ophthalmoscopes